Literature DB >> 10457226

DNA activates human immune cells through a CpG sequence-dependent manner.

M Bauer1, K Heeg, H Wagner, G B Lipford.   

Abstract

While bacterial DNA and cytosine-guanosine-dinucleotide-containing oligonucleotides (CpG ODN) are well described activators of murine immune cells, their effect on human cells is inconclusive. We investigated their properties on human peripheral blood mononuclear cells (PBMC) and subsets thereof, such as purified monocytes, T and B cells. Here we demonstrate that bacterial DNA and CpG ODN induce proliferation of B cells, while other subpopulations, such as monocytes and T cells, did not proliferate. PBMC mixed cell cultures, as well as purified monocytes, produced interleukin-6 (IL-6), IL-12 and tumour necrosis factor-alpha upon stimulation with bacterial DNA; however, only IL-6 and IL-12 secretion became induced upon CpG ODN stimulation. We conclude that monocytes, but not B or T cells, represent the prime source of cytokines. Monocytes up-regulated expression of antigen-presenting, major histocompatibility complex class I and class II molecules in response to CpG DNA. In addition, both monocytes and B cells up-regulate costimulatory CD86 and CD40 molecules. The activation by CpG ODN depended on sequence motifs containing the core dinucleotide CG since destruction of the motif strongly reduced immunostimulatory potential.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457226      PMCID: PMC2326885          DOI: 10.1046/j.1365-2567.1999.00811.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells.

Authors:  S Bendigs; U Salzer; G B Lipford; H Wagner; K Heeg
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

2.  In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG.

Authors:  S Shimada; O Yano; T Tokunaga
Journal:  Jpn J Cancer Res       Date:  1986-08

3.  Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells.

Authors:  T Tokunaga; O Yano; E Kuramoto; Y Kimura; T Yamamoto; T Kataoka; S Yamamoto
Journal:  Microbiol Immunol       Date:  1992       Impact factor: 1.955

4.  CpG motifs in bacterial DNA trigger direct B-cell activation.

Authors:  A M Krieg; A K Yi; S Matson; T J Waldschmidt; G A Bishop; R Teasdale; G A Koretzky; D M Klinman
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

5.  DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth.

Authors:  S Yamamoto; T Yamamoto; S Shimada; E Kuramoto; O Yano; T Kataoka; T Tokunaga
Journal:  Microbiol Immunol       Date:  1992       Impact factor: 1.955

6.  Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide.

Authors:  A J Ulmer; W Feist; H Heine; T Kirikae; F Kirikae; S Kusumoto; T Kusama; H Brade; U Schade; E T Rietschel
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

7.  Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA.

Authors:  J P Messina; G S Gilkeson; D S Pisetsky
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

8.  Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.

Authors:  T Tokunaga; H Yamamoto; S Shimada; H Abe; T Fukuda; Y Fujisawa; Y Furutani; O Yano; T Kataoka; T Sudo
Journal:  J Natl Cancer Inst       Date:  1984-04       Impact factor: 13.506

9.  In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG.

Authors:  S Yamamoto; E Kuramoto; S Shimada; T Tokunaga
Journal:  Jpn J Cancer Res       Date:  1988-07

10.  Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro.

Authors:  T Yamamoto; S Yamamoto; T Kataoka; K Komuro; M Kohase; T Tokunaga
Journal:  Jpn J Cancer Res       Date:  1994-08
View more
  22 in total

1.  Hierarchical recognition of CpG motifs expressed by immunostimulatory oligodeoxynucleotides.

Authors:  D M Klinman; D Currie
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

2.  Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16.

Authors:  Tuo Li; Benjamin A Diner; Jin Chen; Ileana M Cristea
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-12       Impact factor: 11.205

3.  A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation.

Authors:  Anne Månsson; Mikael Adner; Ulf Höckerfelt; Lars-Olaf Cardell
Journal:  Immunology       Date:  2006-06-16       Impact factor: 7.397

4.  Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.

Authors:  S Bauer; C J Kirschning; H Häcker; V Redecke; S Hausmann; S Akira; H Wagner; G B Lipford
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

5.  Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs.

Authors:  Barbara Flynn; Vivian Wang; David L Sacks; Robert A Seder; Daniela Verthelyi
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide.

Authors:  L K Shoda; K A Kegerreis; C E Suarez; I Roditi; R S Corral; G M Bertot; J Norimine; W C Brown
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant.

Authors:  Eugene M A van Rooij; Harrie L Glansbeek; Luuk A T Hilgers; Eddie G te Lintelo; Yolanda E de Visser; Wim J A Boersma; Bart L Haagmans; Andre T J Bianchi
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs.

Authors:  Jan L Bjersing; Kristina Eriksson; Andrej Tarkowski; L Vincent Collins
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

9.  A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.

Authors:  Andriy V Kubarenko; Satish Ranjan; Anna Rautanen; Tara C Mills; Sunny Wong; Fredrik Vannberg; Michael Neumaier; Isabelle Bekeredjian-Ding; Adrian V S Hill; Parviz Ahmad-Nejad; Alexander N R Weber
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

10.  Restricted cytokine production from mouse peritoneal macrophages in culture in spite of extensive uptake of plasmid DNA.

Authors:  Kei Yasuda; Hiroki Kawano; Ikuko Yamane; Yoshiyuki Ogawa; Takaharu Yoshinaga; Makiya Nishikawa; Yoshinobu Takakura
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.